However, it remained unclear whether somatic mutations/deletions of BAP1 have a similarly favorable prognosis in sporadic MM, or if somatic BAP1 alterations are a poor prognostic marker, as is the case for uveal melanoma and clear cell renal cell carcinoma (67, 68). The gene discussed is BAP1; the disease is Miyoshi myopathy.